Global Microneedle Drug Delivery Systems Market By Type (Solid, Hollow, Coated, Dissolving, Others), By Application (Drug Delivery (Protein, Water-Soluble Molecule, Others), Vaccine Delivery, Cancer Therapy, Others), By Material (Silicon, Titanium, Stainless steel, Polymers, Others) By End Users (Hospitals, Surgical Centers, Diagnostic Laboratories, Research Laboratories, Others), By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
A new type of delivery system known as microneedles aids in improving drug delivery through this route and overcoming the various issues associated with conventional formulations. A microneedle device is created by arranging hundreds of microneedles in arrays on a tiny patch to deliver a sufficient amount of drug to provide the desired therapeutic response. Considering the shortcomings of both the hypodermic needle and the transdermal patch, the microneedle drug delivery system was developed and is thought to be a hybrid of the two. Microneedles provide highly accurate reproducible results with minimal inter-subject variability in bioavailability, in addition to improved therapeutic benefits. When oral administration of medication is not possible, they can be used in instead. The increasing prevalence of chronic illnesses and the availability of advanced microneedles is driving sales of microneedle drug delivery systems market over the projection period. The availability of safer alternatives to the traditional hypodermic injection, which is minimally invasive and allows for pain-free administration, is driving up demand for microneedle drug delivery systems. However, high expenditure costs and a scarcity of skilled medical workers will inhibit market growth. Furthermore, to accelerate market growth, major companies such as PharmaTher Holdings Ltd., a clinical-stage psychedelics biotech company, and TSRL, Inc, a company focused on developing microneedle patches for the delivery of antivirals for the treatment of influenza, are pleased to announce that PharmaTher and TSRL have entered into a co-development agreement to jointly develop a microneedle array patch with the goal of managing the manufacturing in June 2021.
COVID-19 was declared a pandemic by the World Health Organization on March 11th, and it has caused millions of instances and a quarter million mortality since then. Pneumonia, lung damage, inflammation, and severe acute respiratory syndrome are all clinical symptoms of this disease (SARS). Transdermal techniques have recently been investigated for vaccines such as COVID-19. Microneedle array technology uses many microscopic projections from a plate to give vaccination in the form of a skin patch, enabling painless antigen administration and better immune response. Many pharmaceutical firms are actively involved in developing microneedle drug delivery for the pandemic. Furthermore, the increased promise of innovation in drug delivery methods in the near future, will promise new opportunities for market participants in the microneedle drug delivery systems market to grow.
In terms of revenue, the global microneedle drug delivery systems market was valued at US$ 5.99 Bn in 2021 growing at a CAGR of 8.34% over the forecast period (2022 – 2030). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Microneedle Drug Delivery Systems Market Revenue & Forecast, (US$ Million), 2015 – 2030
Type Outlook
The global microneedle drug delivery systems market has been divided into several segments, including solid, hollow, coated, dissolving and others. The hollow segment dominated the market in 2021 owing to growing chronic diseases such as cardiovascular or hemodynamic disorders in the developing economies. Hollow microneedles have an empty area within that it is filled with medication dispersion or solution. They are pierced at the tips. The medicine is directly deposited into the epidermis or higher dermis layer after being inserted into the skin. It is mostly utilized for high molecular weight molecules like proteins, vaccines, and oligonucleotides.
Application Outlook:
Based on application, the vaccine delivery segment in the global microneedle drug delivery systems market is projected to be one of the fastest-growing segments over the forecast period due to the emergence of Covid-19 pandemic and other viruses. In June 2021, UNICEF introduced a main public campaign calling on well-supplied donor economies to share doses with others. As a result, more donated dosages started to arrive at COVAX. UNICEF distributed 500 million doses given to 31 countries by February 2022.
End Users Outlook:
Based on end-users, the global microneedle drug delivery systems market has been classified into hospitals, surgical centers, diagnostic laboratories, research laboratories and others. The specialty centers segment is expected to be the fastest-growing segment over the forecast period due to the availability of new technology in surgical centers and the reason that recovering in the patient's home is generally simpler than an in-hospital stay and convenient accessibility.
Region Outlook:
Based on regions, North America dominated the market in 2021 in the global microneedle drug delivery systems market owing to the highest healthcare spending for infrastructure improvements and increased research and development (R&D) activities in the region. Furthermore, the growing importance of patient safety and outcomes are also some significant factors that are boosting growth avenues in the regional market.
Competitive Landscape
The report provides both, qualitative and quantitative research of the global microneedle drug delivery systems market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the global microneedle drug delivery systems market are
- 3M Company
- AdminMed / nanoBioSciences LLC
- CosMED Pharmaceutical Co. Ltd.
- ENDODERMA CO., LTD.
- Microdermics Inc.
- Nanopass Tech
- NITTO DENKO CORPORATION
- QUADMEDICINE
- Raphas Co., Ltd.
- SNvia Co. Ltd.
- TheraJect, Inc.
- Trelleborg Group
- VAXXAS
- Zealand Pharma A/S
- Zosano Pharma Corporation
- Other Market Participants
Global Microneedle Drug Delivery Systems Market:
- By Type
- Solid
- Hollow
- Coated
- Dissolving
- Others
- By Material
- Silicon
- Titanium
- Stainless steel
- Polymers
- Others
- By Application
- Drug Delivery
- Protein
- Water-soluble molecule
- Others
- Vaccine Delivery
- Cancer therapy
- Others
- Drug Delivery
- By End Users
- Hospitals
- Surgical Centers
- Diagnostic Laboratories
- Research Laboratories
- Others
- By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- North America
Rest of Latin America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2021
1.2.2. Base
Year: 2021
1.2.3. Forecast
Years: 2022 – 2030
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Microneedle Drug Delivery Systems Market
6. Market Synopsis:
Microneedle Drug Delivery Systems Market
7. Microneedle Drug Delivery Systems Market Analysis:
Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in
Microneedle Drug Delivery Systems Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Microneedle Drug Delivery Systems Market
7.6. Porter’s
Five Force Analysis
7.7. Impact of
Covid-19 on Microneedle Drug Delivery Systems Market
8. Global Microneedle Drug Delivery Systems Market Analysis and
Forecasts, 2022 – 2030
8.1. Overview
8.1.1. Global
Microneedle Drug Delivery Systems Market Revenue (US$ Mn)
8.2. Global
Microneedle Drug Delivery Systems Market Revenue (US$ Mn) and Forecasts, By
Type
8.2.1. Solid
8.2.1.1. Definition
8.2.1.2. Market Estimation and Penetration, 2015 - 2021
8.2.1.3. Market Forecast, 2022 – 2030
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.1.5. Regional Bifurcation
8.2.1.5.1. North America
8.2.1.5.1.1. Market
Estimation, 2015 - 2021
8.2.1.5.1.2. Market
Forecast, 2022 – 2030
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 - 2021
8.2.1.5.2.2. Market
Forecast, 2022 – 2030
8.2.1.5.3. Asia Pacific
8.2.1.5.3.1. Market
Estimation, 2015 - 2021
8.2.1.5.3.2. Market
Forecast, 2022 – 2030
8.2.1.5.4. Middle East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 - 2021
8.2.1.5.4.2. Market
Forecast, 2022 – 2030
8.2.1.5.5. Latin America
8.2.1.5.5.1. Market
Estimation, 2015 - 2021
8.2.1.5.5.2. Market
Forecast, 2022 – 2030
8.2.2. Hollow
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 - 2021
8.2.2.3. Market Forecast, 2022 – 2030
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market
Estimation, 2015 - 2021
8.2.2.5.1.2. Market
Forecast, 2022 – 2030
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 - 2021
8.2.2.5.2.2. Market
Forecast, 2022 – 2030
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market
Estimation, 2015 - 2021
8.2.2.5.3.2. Market
Forecast, 2022 – 2030
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 - 2021
8.2.2.5.4.2. Market
Forecast, 2022 – 2030
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market
Estimation, 2015 - 2021
8.2.2.5.5.2. Market
Forecast, 2022 – 2030
8.2.3. Coated
8.2.3.1. Definition
8.2.3.2. Market Estimation and Penetration, 2015 - 2021
8.2.3.3. Market Forecast, 2022 – 2030
8.2.3.4. Compound Annual Growth Rate (CAGR)
8.2.3.5. Regional Bifurcation
8.2.3.5.1. North America
8.2.3.5.1.1. Market
Estimation, 2015 - 2021
8.2.3.5.1.2. Market
Forecast, 2022 – 2030
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 - 2021
8.2.3.5.2.2. Market
Forecast, 2022 – 2030
8.2.3.5.3. Asia Pacific
8.2.3.5.3.1. Market
Estimation, 2015 - 2021
8.2.3.5.3.2. Market
Forecast, 2022 – 2030
8.2.3.5.4. Middle East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 - 2021
8.2.3.5.4.2. Market
Forecast, 2022 – 2030
8.2.3.5.5. Latin America
8.2.3.5.5.1. Market
Estimation, 2015 - 2021
8.2.3.5.5.2. Market
Forecast, 2022 – 2030
8.2.4. Dissolving
8.2.4.1. Definition
8.2.4.2. Market Estimation and Penetration, 2015 - 2021
8.2.4.3. Market Forecast, 2022 – 2030
8.2.4.4. Compound Annual Growth Rate (CAGR)
8.2.4.5. Regional Bifurcation
8.2.4.5.1. North America
8.2.4.5.1.1. Market
Estimation, 2015 - 2021
8.2.4.5.1.2. Market
Forecast, 2022 – 2030
8.2.4.5.2. Europe
8.2.4.5.2.1. Market
Estimation, 2015 - 2021
8.2.4.5.2.2. Market
Forecast, 2022 – 2030
8.2.4.5.3. Asia Pacific
8.2.4.5.3.1. Market
Estimation, 2015 - 2021
8.2.4.5.3.2. Market
Forecast, 2022 – 2030
8.2.4.5.4. Middle East and Africa
8.2.4.5.4.1. Market
Estimation, 2015 - 2021
8.2.4.5.4.2. Market
Forecast, 2022 – 2030
8.2.4.5.5. Latin America
8.2.4.5.5.1. Market
Estimation, 2015 - 2021
8.2.4.5.5.2. Market
Forecast, 2022 – 2030
8.2.5. Others
8.2.5.1. Definition
8.2.5.2. Market Estimation and Penetration, 2015 - 2021
8.2.5.3. Market Forecast, 2022 – 2030
8.2.5.4. Compound Annual Growth Rate (CAGR)
8.2.5.5. Regional Bifurcation
8.2.5.5.1. North America
8.2.5.5.1.1. Market
Estimation, 2015 - 2021
8.2.5.5.1.2. Market
Forecast, 2022 – 2030
8.2.5.5.2. Europe
8.2.5.5.2.1. Market
Estimation, 2015 - 2021
8.2.5.5.2.2. Market
Forecast, 2022 – 2030
8.2.5.5.3. Asia Pacific
8.2.5.5.3.1. Market
Estimation, 2015 - 2021
8.2.5.5.3.2. Market
Forecast, 2022 – 2030
8.2.5.5.4. Middle East and Africa
8.2.5.5.4.1. Market
Estimation, 2015 - 2021
8.2.5.5.4.2. Market
Forecast, 2022 – 2030
8.2.5.5.5. Latin America
8.2.5.5.5.1. Market
Estimation, 2015 - 2021
8.2.5.5.5.2. Market
Forecast, 2022 – 2030
8.3. Key
Segment for Channeling Investments
8.3.1. By Type
9. Global Microneedle Drug Delivery Systems Market Analysis and
Forecasts, 2022 – 2030
9.1. Overview
9.2. Global
Microneedle Drug Delivery Systems Market Revenue (US$ Mn) and Forecasts, By
Material
9.2.1. Silicon
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 - 2021
9.2.1.3. Market Forecast, 2022 – 2030
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market
Estimation, 2015 - 2021
9.2.1.5.1.2. Market
Forecast, 2022 – 2030
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 - 2021
9.2.1.5.2.2. Market
Forecast, 2022 – 2030
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market
Estimation, 2015 - 2021
9.2.1.5.3.2. Market
Forecast, 2022 – 2030
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 - 2021
9.2.1.5.4.2. Market
Forecast, 2022 – 2030
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market
Estimation, 2015 - 2021
9.2.1.5.5.2. Market
Forecast, 2022 – 2030
9.2.2. Titanium
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 - 2021
9.2.2.3. Market Forecast, 2022 – 2030
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market
Estimation, 2015 - 2021
9.2.2.5.1.2. Market
Forecast, 2022 – 2030
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 - 2021
9.2.2.5.2.2. Market
Forecast, 2022 – 2030
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market
Estimation, 2015 - 2021
9.2.2.5.3.2. Market
Forecast, 2022 – 2030
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 - 2021
9.2.2.5.4.2. Market
Forecast, 2022 – 2030
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market
Estimation, 2015 - 2021
9.2.2.5.5.2. Market
Forecast, 2022 – 2030
9.2.3. Stainless
steel
9.2.3.1. Definition
9.2.3.2. Market Estimation and Penetration, 2015 - 2021
9.2.3.3. Market Forecast, 2022 – 2030
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market
Estimation, 2015 - 2021
9.2.3.5.1.2. Market
Forecast, 2022 – 2030
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 - 2021
9.2.3.5.2.2. Market
Forecast, 2022 – 2030
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market
Estimation, 2015 - 2021
9.2.3.5.3.2. Market
Forecast, 2022 – 2030
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 - 2021
9.2.3.5.4.2. Market
Forecast, 2022 – 2030
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market
Estimation, 2015 - 2021
9.2.3.5.5.2. Market
Forecast, 2022 – 2030
9.2.4. Polymers
9.2.4.1. Definition
9.2.4.2. Market Estimation and Penetration, 2015 - 2021
9.2.4.3. Market Forecast, 2022 – 2030
9.2.4.4. Compound Annual Growth Rate (CAGR)
9.2.4.5. Regional Bifurcation
9.2.4.5.1. North America
9.2.4.5.1.1. Market
Estimation, 2015 - 2021
9.2.4.5.1.2. Market
Forecast, 2022 – 2030
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2015 - 2021
9.2.4.5.2.2. Market
Forecast, 2022 – 2030
9.2.4.5.3. Asia Pacific
9.2.4.5.3.1. Market
Estimation, 2015 - 2021
9.2.4.5.3.2. Market
Forecast, 2022 – 2030
9.2.4.5.4. Middle East and Africa
9.2.4.5.4.1. Market
Estimation, 2015 - 2021
9.2.4.5.4.2. Market
Forecast, 2022 – 2030
9.2.4.5.5. Latin America
9.2.4.5.5.1. Market
Estimation, 2015 - 2021
9.2.4.5.5.2. Market
Forecast, 2022 – 2030
9.2.5. Others
9.2.5.1. Definition
9.2.5.2. Market Estimation and Penetration, 2015 - 2021
9.2.5.3. Market Forecast, 2022 – 2030
9.2.5.4. Compound Annual Growth Rate (CAGR)
9.2.5.5. Regional Bifurcation
9.2.5.5.1. North America
9.2.5.5.1.1. Market
Estimation, 2015 - 2021
9.2.5.5.1.2. Market
Forecast, 2022 – 2030
9.2.5.5.2. Europe
9.2.5.5.2.1. Market
Estimation, 2015 - 2021
9.2.5.5.2.2. Market
Forecast, 2022 – 2030
9.2.5.5.3. Asia Pacific
9.2.5.5.3.1. Market
Estimation, 2015 - 2021
9.2.5.5.3.2. Market
Forecast, 2022 – 2030
9.2.5.5.4. Middle East and Africa
9.2.5.5.4.1. Market
Estimation, 2015 - 2021
9.2.5.5.4.2. Market
Forecast, 2022 – 2030
9.2.5.5.5. Latin America
9.2.5.5.5.1. Market
Estimation, 2015 - 2021
9.2.5.5.5.2. Market
Forecast, 2022 – 2030
9.3. Key
Segment for Channeling Investments
9.3.1. By
Material
10. Global Microneedle Drug Delivery Systems Market Analysis and
Forecasts, 2022 – 2030
10.1. Overview
10.2. Global
Microneedle Drug Delivery Systems Market Revenue (US$ Mn) and Forecasts, By
Application
10.2.1. Drug
Delivery (Definition, Market Estimation and Penetration, 2015 - 2021, Market
Estimation (2015 - 2021), Market Forecast (2022 – 2030), Compound Annual Growth
Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle
East and Africa, Latin America) and Information on Protein, Water-Soluble
Molecule, Others)
10.2.1.1. Protein
10.2.1.2. Water-Soluble Molecule
10.2.1.3. Others
10.2.2. Vaccine
Delivery
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 - 2021
10.2.2.3. Market Forecast, 2022 – 2030
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market
Estimation, 2015 - 2021
10.2.2.5.1.2. Market
Forecast, 2022 – 2030
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 - 2021
10.2.2.5.2.2. Market
Forecast, 2022 – 2030
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market
Estimation, 2015 - 2021
10.2.2.5.3.2. Market
Forecast, 2022 – 2030
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 - 2021
10.2.2.5.4.2. Market
Forecast, 2022 – 2030
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market
Estimation, 2015 - 2021
10.2.2.5.5.2. Market
Forecast, 2022 – 2030
10.2.3. Cancer
therapy
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 - 2021
10.2.3.3. Market Forecast, 2022 – 2030
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market
Estimation, 2015 - 2021
10.2.3.5.1.2. Market
Forecast, 2022 – 2030
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 - 2021
10.2.3.5.2.2. Market
Forecast, 2022 – 2030
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market
Estimation, 2015 - 2021
10.2.3.5.3.2. Market
Forecast, 2022 – 2030
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 - 2021
10.2.3.5.4.2. Market
Forecast, 2022 – 2030
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market
Estimation, 2015 - 2021
10.2.3.5.5.2. Market
Forecast, 2022 – 2030
10.2.4. Others
10.2.4.1. Definition
10.2.4.2. Market Estimation and Penetration, 2015 - 2021
10.2.4.3. Market Forecast, 2022 – 2030
10.2.4.4. Compound Annual Growth Rate (CAGR)
10.2.4.5. Regional Bifurcation
10.2.4.5.1. North America
10.2.4.5.1.1. Market
Estimation, 2015 - 2021
10.2.4.5.1.2. Market
Forecast, 2022 – 2030
10.2.4.5.2. Europe
10.2.4.5.2.1. Market
Estimation, 2015 - 2021
10.2.4.5.2.2. Market
Forecast, 2022 – 2030
10.2.4.5.3. Asia Pacific
10.2.4.5.3.1. Market
Estimation, 2015 - 2021
10.2.4.5.3.2. Market
Forecast, 2022 – 2030
10.2.4.5.4. Middle East and Africa
10.2.4.5.4.1. Market
Estimation, 2015 - 2021
10.2.4.5.4.2. Market
Forecast, 2022 – 2030
10.2.4.5.5. Latin America
10.2.4.5.5.1. Market
Estimation, 2015 - 2021
10.2.4.5.5.2. Market
Forecast, 2022 – 2030
10.3. Key
Segment for Channeling Investments
10.3.1. By
Application
11. Global Microneedle Drug Delivery Systems Market Analysis and
Forecasts, 2022 – 2030
11.1. Overview
11.2. Global
Microneedle Drug Delivery Systems Market Revenue (US$ Mn) and Forecasts, By End
Users
11.2.1. Hospitals
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2015 - 2021
11.2.1.3. Market Forecast, 2022 – 2030
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1. Market
Estimation, 2015 - 2021
11.2.1.5.1.2. Market
Forecast, 2022 – 2030
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 - 2021
11.2.1.5.2.2. Market
Forecast, 2022 – 2030
11.2.1.5.3. Asia Pacific
11.2.1.5.3.1. Market
Estimation, 2015 - 2021
11.2.1.5.3.2. Market
Forecast, 2022 – 2030
11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 - 2021
11.2.1.5.4.2. Market
Forecast, 2022 – 2030
11.2.1.5.5. Latin America
11.2.1.5.5.1. Market
Estimation, 2015 - 2021
11.2.1.5.5.2. Market
Forecast, 2022 – 2030
11.2.2. Surgical
Centers
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2015 - 2021
11.2.2.3. Market Forecast, 2022 – 2030
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North America
11.2.2.5.1.1. Market
Estimation, 2015 - 2021
11.2.2.5.1.2. Market
Forecast, 2022 – 2030
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 - 2021
11.2.2.5.2.2. Market
Forecast, 2022 – 2030
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1. Market
Estimation, 2015 - 2021
11.2.2.5.3.2. Market
Forecast, 2022 – 2030
11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 - 2021
11.2.2.5.4.2. Market
Forecast, 2022 – 2030
11.2.2.5.5. Latin America
11.2.2.5.5.1. Market
Estimation, 2015 - 2021
11.2.2.5.5.2. Market
Forecast, 2022 – 2030
11.2.3. Diagnostic
Laboratories
11.2.3.1. Definition
11.2.3.2. Market Estimation and Penetration, 2015 - 2021
11.2.3.3. Market Forecast, 2022 – 2030
11.2.3.4. Compound Annual Growth Rate (CAGR)
11.2.3.5. Regional Bifurcation
11.2.3.5.1. North America
11.2.3.5.1.1. Market
Estimation, 2015 - 2021
11.2.3.5.1.2. Market
Forecast, 2022 – 2030
11.2.3.5.2. Europe
11.2.3.5.2.1. Market
Estimation, 2015 - 2021
11.2.3.5.2.2. Market
Forecast, 2022 – 2030
11.2.3.5.3. Asia Pacific
11.2.3.5.3.1. Market
Estimation, 2015 - 2021
11.2.3.5.3.2. Market
Forecast, 2022 – 2030
11.2.3.5.4. Middle East and Africa
11.2.3.5.4.1. Market
Estimation, 2015 - 2021
11.2.3.5.4.2. Market
Forecast, 2022 – 2030
11.2.3.5.5. Latin America
11.2.3.5.5.1. Market
Estimation, 2015 - 2021
11.2.3.5.5.2. Market
Forecast, 2022 – 2030
11.2.4. Research
Laboratories
11.2.4.1. Definition
11.2.4.2. Market Estimation and Penetration, 2015 - 2021
11.2.4.3. Market Forecast, 2022 – 2030
11.2.4.4. Compound Annual Growth Rate (CAGR)
11.2.4.5. Regional Bifurcation
11.2.4.5.1. North America
11.2.4.5.1.1. Market
Estimation, 2015 - 2021
11.2.4.5.1.2. Market
Forecast, 2022 – 2030
11.2.4.5.2. Europe
11.2.4.5.2.1. Market
Estimation, 2015 - 2021
11.2.4.5.2.2. Market
Forecast, 2022 – 2030
11.2.4.5.3. Asia Pacific
11.2.4.5.3.1. Market
Estimation, 2015 - 2021
11.2.4.5.3.2. Market
Forecast, 2022 – 2030
11.2.4.5.4. Middle East and Africa
11.2.4.5.4.1. Market
Estimation, 2015 - 2021
11.2.4.5.4.2. Market
Forecast, 2022 – 2030
11.2.4.5.5. Latin America
11.2.4.5.5.1. Market
Estimation, 2015 - 2021
11.2.4.5.5.2. Market
Forecast, 2022 – 2030
11.2.5. Others
11.2.5.1. Definition
11.2.5.2. Market Estimation and Penetration, 2015 - 2021
11.2.5.3. Market Forecast, 2022 – 2030
11.2.5.4. Compound Annual Growth Rate (CAGR)
11.2.5.5. Regional Bifurcation
11.2.5.5.1. North America
11.2.5.5.1.1. Market
Estimation, 2015 - 2021
11.2.5.5.1.2. Market
Forecast, 2022 – 2030
11.2.5.5.2. Europe
11.2.5.5.2.1. Market
Estimation, 2015 - 2021
11.2.5.5.2.2. Market
Forecast, 2022 – 2030
11.2.5.5.3. Asia Pacific
11.2.5.5.3.1. Market
Estimation, 2015 - 2021
11.2.5.5.3.2. Market
Forecast, 2022 – 2030
11.2.5.5.4. Middle East and Africa
11.2.5.5.4.1. Market
Estimation, 2015 - 2021
11.2.5.5.4.2. Market
Forecast, 2022 – 2030
11.2.5.5.5. Latin America
11.2.5.5.5.1. Market
Estimation, 2015 - 2021
11.2.5.5.5.2. Market
Forecast, 2022 – 2030
11.3. Key
Segment for Channeling Investments
11.3.1. By End Users
12. North America Microneedle Drug Delivery Systems Market
Analysis and Forecasts, 2022 – 2030
12.1. Overview
12.1.1. North
America Microneedle Drug Delivery Systems Market Revenue (US$ Mn)
12.2. North
America Microneedle Drug Delivery Systems Market Revenue (US$ Mn) and Forecasts,
By Type
12.2.1. Solid
12.2.2. Hollow
12.2.3. Coated
12.2.4. Dissolving
12.2.5. Others
12.3. North
America Microneedle Drug Delivery Systems Market Revenue (US$ Mn) and
Forecasts, By Material
12.3.1. Silicon
12.3.2. Titanium
12.3.3. Stainless
steel
12.3.4. Polymers
12.3.5. Others
12.4. North
America Microneedle Drug Delivery Systems Market Revenue (US$ Mn) and
Forecasts, By Application
12.4.1. Drug
Delivery
12.4.1.1. Protein
12.4.1.2. Water-Soluble Molecule
12.4.1.3. Others
12.4.2. Vaccine
Delivery
12.4.3. Cancer
therapy
12.4.4. Others
12.5. North
America Microneedle Drug Delivery Systems Market Revenue (US$ Mn) and
Forecasts, By End Users
12.5.1. Hospitals
12.5.2. Surgical
Centers
12.5.3. Diagnostic
Laboratories
12.5.4. Research
Laboratories
12.5.5. Others
12.6. North
America Microneedle Drug Delivery Systems Market Revenue (US$ Mn) and
Forecasts, By Country
12.6.1. U.S
12.6.1.1. U.S Microneedle Drug Delivery Systems Market Revenue (US$ Mn)
and Forecasts, By Type
12.6.1.1.1. Solid
12.6.1.1.2. Hollow
12.6.1.1.3. Coated
12.6.1.1.4. Dissolving
12.6.1.1.5. Others
12.6.1.2. U.S Microneedle Drug Delivery Systems Market Revenue (US$ Mn)
and Forecasts, By Material
12.6.1.2.1. Silicon
12.6.1.2.2. Titanium
12.6.1.2.3. Stainless steel
12.6.1.2.4. Polymers
12.6.1.2.5. Others
12.6.1.3. U.S Microneedle Drug Delivery Systems Market Revenue (US$ Mn)
and Forecasts, By Application
12.6.1.3.1. Drug Delivery
12.6.1.3.1.1. Protein
12.6.1.3.1.2. Water-Soluble
Molecule
12.6.1.3.1.3. Others
12.6.1.3.2. Vaccine Delivery
12.6.1.3.3. Cancer therapy
12.6.1.3.4. Others
12.6.1.4. U.S Microneedle Drug Delivery Systems Market Revenue (US$ Mn)
and Forecasts, By End Users
12.6.1.4.1. Hospitals
12.6.1.4.2. Surgical Centers
12.6.1.4.3. Diagnostic Laboratories
12.6.1.4.4. Research Laboratories
12.6.1.4.5. Others
12.6.2. Canada
12.6.2.1. Canada Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Type
12.6.2.1.1. Solid
12.6.2.1.2. Hollow
12.6.2.1.3. Coated
12.6.2.1.4. Dissolving
12.6.2.1.5. Others
12.6.2.2. Canada Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Material
12.6.2.2.1. Silicon
12.6.2.2.2. Titanium
12.6.2.2.3. Stainless steel
12.6.2.2.4. Polymers
12.6.2.2.5. Others
12.6.2.3. Canada Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Application
12.6.2.3.1. Drug Delivery
12.6.2.3.1.1. Protein
12.6.2.3.1.2. Water-Soluble
Molecule
12.6.2.3.1.3. Others
12.6.2.3.2. Vaccine Delivery
12.6.2.3.3. Cancer therapy
12.6.2.3.4. Others
12.6.2.4. Canada Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By End Users
12.6.2.4.1. Hospitals
12.6.2.4.2. Surgical Centers
12.6.2.4.3. Diagnostic Laboratories
12.6.2.4.4. Research Laboratories
12.6.2.4.5. Others
12.6.3. Mexico
12.6.3.1. Mexico Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Type
12.6.3.1.1. Solid
12.6.3.1.2. Hollow
12.6.3.1.3. Coated
12.6.3.1.4. Dissolving
12.6.3.1.5. Others
12.6.3.2. Mexico Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Material
12.6.3.2.1. Silicon
12.6.3.2.2. Titanium
12.6.3.2.3. Stainless steel
12.6.3.2.4. Polymers
12.6.3.2.5. Others
12.6.3.3. Mexico Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Application
12.6.3.3.1. Drug Delivery
12.6.3.3.1.1. Protein
12.6.3.3.1.2. Water-Soluble
Molecule
12.6.3.3.1.3. Others
12.6.3.3.2. Vaccine Delivery
12.6.3.3.3. Cancer therapy
12.6.3.3.4. Others
12.6.3.4. Mexico Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By End Users
12.6.3.4.1. Hospitals
12.6.3.4.2. Surgical Centers
12.6.3.4.3. Diagnostic Laboratories
12.6.3.4.4. Research Laboratories
12.6.3.4.5. Others
12.6.4. Rest of
North America
12.6.4.1. Rest of North America Microneedle Drug Delivery Systems Market
Revenue (US$ Mn) and Forecasts, By Type
12.6.4.1.1. Solid
12.6.4.1.2. Hollow
12.6.4.1.3. Coated
12.6.4.1.4. Dissolving
12.6.4.1.5. Others
12.6.4.2. Rest of North America Microneedle Drug Delivery Systems Market
Revenue (US$ Mn) and Forecasts, By Material
12.6.4.2.1. Silicon
12.6.4.2.2. Titanium
12.6.4.2.3. Stainless steel
12.6.4.2.4. Polymers
12.6.4.2.5. Others
12.6.4.3. Rest of North America Microneedle Drug Delivery Systems Market
Revenue (US$ Mn) and Forecasts, By Application
12.6.4.3.1. Drug Delivery
12.6.4.3.1.1. Protein
12.6.4.3.1.2. Water-Soluble
Molecule
12.6.4.3.1.3. Others
12.6.4.3.2. Vaccine Delivery
12.6.4.3.3. Cancer therapy
12.6.4.3.4. Others
12.6.4.4. Rest of North America Microneedle Drug Delivery Systems Market
Revenue (US$ Mn) and Forecasts, By End Users
12.6.4.4.1. Hospitals
12.6.4.4.2. Surgical Centers
12.6.4.4.3. Diagnostic Laboratories
12.6.4.4.4. Research Laboratories
12.6.4.4.5. Others
12.7. Key
Segment for Channeling Investments
12.7.1. By
Country
12.7.2. By Type
12.7.3. By
Material
12.7.4. By
Application
12.7.5. By End
Users
13. Europe Microneedle Drug Delivery Systems Market Analysis and
Forecasts, 2022 – 2030
13.1. Overview
13.1.1. Europe
Microneedle Drug Delivery Systems Market Revenue (US$ Mn)
13.2. Europe
Microneedle Drug Delivery Systems Market Revenue (US$ Mn) and Forecasts, By
Type
13.2.1. Solid
13.2.2. Hollow
13.2.3. Coated
13.2.4. Dissolving
13.2.5. Others
13.3. Europe
Microneedle Drug Delivery Systems Market Revenue (US$ Mn) and Forecasts, By
Material
13.3.1. Silicon
13.3.2. Titanium
13.3.3. Stainless
steel
13.3.4. Polymers
13.3.5. Others
13.4. Europe
Microneedle Drug Delivery Systems Market Revenue (US$ Mn) and Forecasts, By
Application
13.4.1. Drug
Delivery
13.4.1.1. Protein
13.4.1.2. Water-Soluble Molecule
13.4.1.3. Others
13.4.2. Vaccine
Delivery
13.4.3. Cancer
therapy
13.4.4. Others
13.5. Europe
Microneedle Drug Delivery Systems Market Revenue (US$ Mn) and Forecasts, By End
Users
13.5.1. Hospitals
13.5.2. Surgical
Centers
13.5.3. Diagnostic
Laboratories
13.5.4. Research
Laboratories
13.5.5. Others
13.6. Europe
Microneedle Drug Delivery Systems Market Revenue (US$ Mn) and Forecasts, By
Country
13.6.1. France
13.6.1.1. France Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Type
13.6.1.1.1. Solid
13.6.1.1.2. Hollow
13.6.1.1.3. Coated
13.6.1.1.4. Dissolving
13.6.1.1.5. Others
13.6.1.2. France Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Material
13.6.1.2.1. Silicon
13.6.1.2.2. Titanium
13.6.1.2.3. Stainless steel
13.6.1.2.4. Polymers
13.6.1.2.5. Others
13.6.1.3. France Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Application
13.6.1.3.1. Drug Delivery
13.6.1.3.1.1. Protein
13.6.1.3.1.2. Water-Soluble
Molecule
13.6.1.3.1.3. Others
13.6.1.3.2. Vaccine Delivery
13.6.1.3.3. Cancer therapy
13.6.1.3.4. Others
13.6.1.4. France Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By End Users
13.6.1.4.1. Hospitals
13.6.1.4.2. Surgical Centers
13.6.1.4.3. Diagnostic Laboratories
13.6.1.4.4. Research Laboratories
13.6.1.4.5. Others
13.6.2. The UK
13.6.2.1. The UK Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Type
13.6.2.1.1. Solid
13.6.2.1.2. Hollow
13.6.2.1.3. Coated
13.6.2.1.4. Dissolving
13.6.2.1.5. Others
13.6.2.2. The UK Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Material
13.6.2.2.1. Silicon
13.6.2.2.2. Titanium
13.6.2.2.3. Stainless steel
13.6.2.2.4. Polymers
13.6.2.2.5. Others
13.6.2.3. The UK Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Application
13.6.2.3.1. Drug Delivery
13.6.2.3.1.1. Protein
13.6.2.3.1.2. Water-Soluble
Molecule
13.6.2.3.1.3. Others
13.6.2.3.2. Vaccine Delivery
13.6.2.3.3. Cancer therapy
13.6.2.3.4. Others
13.6.2.4. The UK Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By End Users
13.6.2.4.1. Hospitals
13.6.2.4.2. Surgical Centers
13.6.2.4.3. Diagnostic Laboratories
13.6.2.4.4. Research Laboratories
13.6.2.4.5. Others
13.6.3. Spain
13.6.3.1. Spain Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Type
13.6.3.1.1. Solid
13.6.3.1.2. Hollow
13.6.3.1.3. Coated
13.6.3.1.4. Dissolving
13.6.3.1.5. Others
13.6.3.2. Spain Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Material
13.6.3.2.1. Silicon
13.6.3.2.2. Titanium
13.6.3.2.3. Stainless steel
13.6.3.2.4. Polymers
13.6.3.2.5. Others
13.6.3.3. Spain Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Application
13.6.3.3.1. Drug Delivery
13.6.3.3.1.1. Protein
13.6.3.3.1.2. Water-Soluble
Molecule
13.6.3.3.1.3. Others
13.6.3.3.2. Vaccine Delivery
13.6.3.3.3. Cancer therapy
13.6.3.3.4. Others
13.6.3.4. Spain Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By End Users
13.6.3.4.1. Hospitals
13.6.3.4.2. Surgical Centers
13.6.3.4.3. Diagnostic Laboratories
13.6.3.4.4. Research Laboratories
13.6.3.4.5. Others
13.6.4. Germany
13.6.4.1. Germany Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Type
13.6.4.1.1. Solid
13.6.4.1.2. Hollow
13.6.4.1.3. Coated
13.6.4.1.4. Dissolving
13.6.4.1.5. Others
13.6.4.2. Germany Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Material
13.6.4.2.1. Silicon
13.6.4.2.2. Titanium
13.6.4.2.3. Stainless steel
13.6.4.2.4. Polymers
13.6.4.2.5. Others
13.6.4.3. Germany Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Application
13.6.4.3.1. Drug Delivery
13.6.4.3.1.1. Protein
13.6.4.3.1.2. Water-Soluble
Molecule
13.6.4.3.1.3. Others
13.6.4.3.2. Vaccine Delivery
13.6.4.3.3. Cancer therapy
13.6.4.3.4. Others
13.6.4.4. Germany Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By End Users
13.6.4.4.1. Hospitals
13.6.4.4.2. Surgical Centers
13.6.4.4.3. Diagnostic Laboratories
13.6.4.4.4. Research Laboratories
13.6.4.4.5. Others
13.6.5. Italy
13.6.5.1. Italy Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Type
13.6.5.1.1. Solid
13.6.5.1.2. Hollow
13.6.5.1.3. Coated
13.6.5.1.4. Dissolving
13.6.5.1.5. Others
13.6.5.2. Italy Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Material
13.6.5.2.1. Silicon
13.6.5.2.2. Titanium
13.6.5.2.3. Stainless steel
13.6.5.2.4. Polymers
13.6.5.2.5. Others
13.6.5.3. Italy Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Application
13.6.5.3.1. Drug Delivery
13.6.5.3.1.1. Protein
13.6.5.3.1.2. Water-Soluble
Molecule
13.6.5.3.1.3. Others
13.6.5.3.2. Vaccine Delivery
13.6.5.3.3. Cancer therapy
13.6.5.3.4. Others
13.6.5.4. Italy Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By End Users
13.6.5.4.1. Hospitals
13.6.5.4.2. Surgical Centers
13.6.5.4.3. Diagnostic Laboratories
13.6.5.4.4. Research Laboratories
13.6.5.4.5. Others
13.6.6. Nordic
Countries
13.6.6.1. Nordic Countries Microneedle Drug Delivery Systems Market
Revenue (US$ Mn) and Forecasts, By Type
13.6.6.1.1. Solid
13.6.6.1.2. Hollow
13.6.6.1.3. Coated
13.6.6.1.4. Dissolving
13.6.6.1.5. Others
13.6.6.2. Nordic Countries Microneedle Drug Delivery Systems Market Revenue
(US$ Mn) and Forecasts, By Material
13.6.6.2.1. Silicon
13.6.6.2.2. Titanium
13.6.6.2.3. Stainless steel
13.6.6.2.4. Polymers
13.6.6.2.5. Others
13.6.6.3. Nordic Countries Microneedle Drug Delivery Systems Market
Revenue (US$ Mn) and Forecasts, By Application
13.6.6.3.1. Drug Delivery
13.6.6.3.1.1. Protein
13.6.6.3.1.2. Water-Soluble
Molecule
13.6.6.3.1.3. Others
13.6.6.3.2. Vaccine Delivery
13.6.6.3.3. Cancer therapy
13.6.6.3.4. Others
13.6.6.4. Nordic Countries Microneedle Drug Delivery Systems Market
Revenue (US$ Mn) and Forecasts, By End Users
13.6.6.4.1. Hospitals
13.6.6.4.2. Surgical Centers
13.6.6.4.3. Diagnostic Laboratories
13.6.6.4.4. Research Laboratories
13.6.6.4.5. Others
13.6.6.5. Nordic Countries Microneedle Drug Delivery Systems Market
Revenue (US$ Mn) and Forecasts, By Country
13.6.6.5.1. Denmark
13.6.6.5.2. Finland
13.6.6.5.3. Iceland
13.6.6.5.4. Sweden
13.6.6.5.5. Norway
13.6.7. Benelux
Union
13.6.7.1. Benelux Union Microneedle Drug Delivery Systems Market Revenue
(US$ Mn) and Forecasts, By Type
13.6.7.1.1. Solid
13.6.7.1.2. Hollow
13.6.7.1.3. Coated
13.6.7.1.4. Dissolving
13.6.7.1.5. Others
13.6.7.2. Benelux Union Microneedle Drug Delivery Systems Market Revenue
(US$ Mn) and Forecasts, By Material
13.6.7.2.1. Silicon
13.6.7.2.2. Titanium
13.6.7.2.3. Stainless steel
13.6.7.2.4. Polymers
13.6.7.2.5. Others
13.6.7.3. Benelux Union Microneedle Drug Delivery Systems Market Revenue
(US$ Mn) and Forecasts, By Application
13.6.7.3.1. Drug Delivery
13.6.7.3.1.1. Protein
13.6.7.3.1.2. Water-Soluble
Molecule
13.6.7.3.1.3. Others
13.6.7.3.2. Vaccine Delivery
13.6.7.3.3. Cancer therapy
13.6.7.3.4. Others
13.6.7.4. Benelux Union Microneedle Drug Delivery Systems Market Revenue
(US$ Mn) and Forecasts, By End Users
13.6.7.4.1. Hospitals
13.6.7.4.2. Surgical Centers
13.6.7.4.3. Diagnostic Laboratories
13.6.7.4.4. Research Laboratories
13.6.7.4.5. Others
13.6.7.5. Benelux Union Microneedle Drug Delivery Systems Market Revenue
(US$ Mn) and Forecasts, By Country
13.6.7.5.1. Belgium
13.6.7.5.2. The Netherlands
13.6.7.5.3. Luxembourg
13.6.8. Rest of
Europe
13.6.8.1. Rest of Europe Microneedle Drug Delivery Systems Market
Revenue (US$ Mn) and Forecasts, By Type
13.6.8.1.1. Solid
13.6.8.1.2. Hollow
13.6.8.1.3. Coated
13.6.8.1.4. Dissolving
13.6.8.1.5. Others
13.6.8.2. Rest of Europe Microneedle Drug Delivery Systems Market
Revenue (US$ Mn) and Forecasts, By Material
13.6.8.2.1. Silicon
13.6.8.2.2. Titanium
13.6.8.2.3. Stainless steel
13.6.8.2.4. Polymers
13.6.8.2.5. Others
13.6.8.3. Rest of Europe Microneedle Drug Delivery Systems Market
Revenue (US$ Mn) and Forecasts, By Application
13.6.8.3.1. Drug Delivery
13.6.8.3.1.1. Protein
13.6.8.3.1.2. Water-Soluble
Molecule
13.6.8.3.1.3. Others
13.6.8.3.2. Vaccine Delivery
13.6.8.3.3. Cancer therapy
13.6.8.3.4. Others
13.6.8.4. Rest of Europe Microneedle Drug Delivery Systems Market
Revenue (US$ Mn) and Forecasts, By End Users
13.6.8.4.1. Hospitals
13.6.8.4.2. Surgical Centers
13.6.8.4.3. Diagnostic Laboratories
13.6.8.4.4. Research Laboratories
13.6.8.4.5. Others
13.7. Key
Segment for Channeling Investments
13.7.1. By
Country
13.7.2. By Type
13.7.3. By
Material
13.7.4. By
Application
13.7.5. By End
Users
14. Asia Pacific Microneedle Drug Delivery Systems Market
Analysis and Forecasts, 2022 – 2030
14.1. Overview
14.1.1. Asia
Pacific Microneedle Drug Delivery Systems Market Revenue (US$ Mn)
14.2. Asia
Pacific Microneedle Drug Delivery Systems Market Revenue (US$ Mn) and
Forecasts, By Type
14.2.1. Solid
14.2.2. Hollow
14.2.3. Coated
14.2.4. Dissolving
14.2.5. Others
14.3. Asia
Pacific Microneedle Drug Delivery Systems Market Revenue (US$ Mn) and
Forecasts, By Material
14.3.1. Silicon
14.3.2. Titanium
14.3.3. Stainless
steel
14.3.4. Polymers
14.3.5. Others
14.4. Asia
Pacific Microneedle Drug Delivery Systems Market Revenue (US$ Mn) and
Forecasts, By Application
14.4.1. Drug
Delivery
14.4.1.1. Protein
14.4.1.2. Water-Soluble Molecule
14.4.1.3. Others
14.4.2. Vaccine
Delivery
14.4.3. Cancer
therapy
14.4.4. Others
14.5. Asia
Pacific Microneedle Drug Delivery Systems Market Revenue (US$ Mn) and
Forecasts, By End Users
14.5.1. Hospitals
14.5.2. Surgical
Centers
14.5.3. Diagnostic
Laboratories
14.5.4. Research
Laboratories
14.5.5. Others
14.6. Asia
Pacific Microneedle Drug Delivery Systems Market Revenue (US$ Mn) and
Forecasts, By Country
14.6.1. China
14.6.1.1. China Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Type
14.6.1.1.1. Solid
14.6.1.1.2. Hollow
14.6.1.1.3. Coated
14.6.1.1.4. Dissolving
14.6.1.1.5. Others
14.6.1.2. China Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Material
14.6.1.2.1. Silicon
14.6.1.2.2. Titanium
14.6.1.2.3. Stainless steel
14.6.1.2.4. Polymers
14.6.1.2.5. Others
14.6.1.3. China Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Application
14.6.1.3.1. Drug Delivery
14.6.1.3.1.1. Protein
14.6.1.3.1.2. Water-Soluble
Molecule
14.6.1.3.1.3. Others
14.6.1.3.2. Vaccine Delivery
14.6.1.3.3. Cancer therapy
14.6.1.3.4. Others
14.6.1.4. China Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By End Users
14.6.1.4.1. Hospitals
14.6.1.4.2. Surgical Centers
14.6.1.4.3. Diagnostic Laboratories
14.6.1.4.4. Research Laboratories
14.6.1.4.5. Others
14.6.2. Japan
14.6.2.1. Japan Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Type
14.6.2.1.1. Solid
14.6.2.1.2. Hollow
14.6.2.1.3. Coated
14.6.2.1.4. Dissolving
14.6.2.1.5. Others
14.6.2.2. Japan Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Material
14.6.2.2.1. Silicon
14.6.2.2.2. Titanium
14.6.2.2.3. Stainless steel
14.6.2.2.4. Polymers
14.6.2.2.5. Others
14.6.2.3. Japan Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Application
14.6.2.3.1. Drug Delivery
14.6.2.3.1.1. Protein
14.6.2.3.1.2. Water-Soluble
Molecule
14.6.2.3.1.3. Others
14.6.2.3.2. Vaccine Delivery
14.6.2.3.3. Cancer therapy
14.6.2.3.4. Others
14.6.2.4. Japan Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By End Users
14.6.2.4.1. Hospitals
14.6.2.4.2. Surgical Centers
14.6.2.4.3. Diagnostic Laboratories
14.6.2.4.4. Research Laboratories
14.6.2.4.5. Others
14.6.3. India
14.6.3.1. India Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Type
14.6.3.1.1. Solid
14.6.3.1.2. Hollow
14.6.3.1.3. Coated
14.6.3.1.4. Dissolving
14.6.3.1.5. Others
14.6.3.2. India Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Material
14.6.3.2.1. Silicon
14.6.3.2.2. Titanium
14.6.3.2.3. Stainless steel
14.6.3.2.4. Polymers
14.6.3.2.5. Others
14.6.3.3. India Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Application
14.6.3.3.1. Drug Delivery
14.6.3.3.1.1. Protein
14.6.3.3.1.2. Water-Soluble
Molecule
14.6.3.3.1.3. Others
14.6.3.3.2. Vaccine Delivery
14.6.3.3.3. Cancer therapy
14.6.3.3.4. Others
14.6.3.4. India Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By End Users
14.6.3.4.1. Hospitals
14.6.3.4.2. Surgical Centers
14.6.3.4.3. Diagnostic Laboratories
14.6.3.4.4. Research Laboratories
14.6.3.4.5. Others
14.6.4. New
Zealand
14.6.4.1. New Zealand Microneedle Drug Delivery Systems Market Revenue
(US$ Mn) and Forecasts, By Type
14.6.4.1.1. Solid
14.6.4.1.2. Hollow
14.6.4.1.3. Coated
14.6.4.1.4. Dissolving
14.6.4.1.5. Others
14.6.4.2. New Zealand Microneedle Drug Delivery Systems Market Revenue
(US$ Mn) and Forecasts, By Material
14.6.4.2.1. Silicon
14.6.4.2.2. Titanium
14.6.4.2.3. Stainless steel
14.6.4.2.4. Polymers
14.6.4.2.5. Others
14.6.4.3. New Zealand Microneedle Drug Delivery Systems Market Revenue
(US$ Mn) and Forecasts, By Application
14.6.4.3.1. Drug Delivery
14.6.4.3.1.1. Protein
14.6.4.3.1.2. Water-Soluble
Molecule
14.6.4.3.1.3. Others
14.6.4.3.2. Vaccine Delivery
14.6.4.3.3. Cancer therapy
14.6.4.3.4. Others
14.6.4.4. New Zealand Microneedle Drug Delivery Systems Market Revenue
(US$ Mn) and Forecasts, By End Users
14.6.4.4.1. Hospitals
14.6.4.4.2. Surgical Centers
14.6.4.4.3. Diagnostic Laboratories
14.6.4.4.4. Research Laboratories
14.6.4.4.5. Others
14.6.5. Australia
14.6.5.1. Australia Microneedle Drug Delivery Systems Market Revenue
(US$ Mn) and Forecasts, By Type
14.6.5.1.1. Solid
14.6.5.1.2. Hollow
14.6.5.1.3. Coated
14.6.5.1.4. Dissolving
14.6.5.1.5. Others
14.6.5.2. Australia Microneedle Drug Delivery Systems Market Revenue
(US$ Mn) and Forecasts, By Material
14.6.5.2.1. Silicon
14.6.5.2.2. Titanium
14.6.5.2.3. Stainless steel
14.6.5.2.4. Polymers
14.6.5.2.5. Others
14.6.5.3. Australia Microneedle Drug Delivery Systems Market Revenue
(US$ Mn) and Forecasts, By Application
14.6.5.3.1. Drug Delivery
14.6.5.3.1.1. Protein
14.6.5.3.1.2. Water-Soluble
Molecule
14.6.5.3.1.3. Others
14.6.5.3.2. Vaccine Delivery
14.6.5.3.3. Cancer therapy
14.6.5.3.4. Others
14.6.5.4. Australia Microneedle Drug Delivery Systems Market Revenue
(US$ Mn) and Forecasts, By End Users
14.6.5.4.1. Hospitals
14.6.5.4.2. Surgical Centers
14.6.5.4.3. Diagnostic Laboratories
14.6.5.4.4. Research Laboratories
14.6.5.4.5. Others
14.6.6. South
Korea
14.6.6.1. South Korea Microneedle Drug Delivery Systems Market Revenue
(US$ Mn) and Forecasts, By Type
14.6.6.1.1. Solid
14.6.6.1.2. Hollow
14.6.6.1.3. Coated
14.6.6.1.4. Dissolving
14.6.6.1.5. Others
14.6.6.2. South Korea Microneedle Drug Delivery Systems Market Revenue
(US$ Mn) and Forecasts, By Material
14.6.6.2.1. Silicon
14.6.6.2.2. Titanium
14.6.6.2.3. Stainless steel
14.6.6.2.4. Polymers
14.6.6.2.5. Others
14.6.6.3. South Korea Microneedle Drug Delivery Systems Market Revenue
(US$ Mn) and Forecasts, By Application
14.6.6.3.1. Drug Delivery
14.6.6.3.1.1. Protein
14.6.6.3.1.2. Water-Soluble
Molecule
14.6.6.3.1.3. Others
14.6.6.3.2. Vaccine Delivery
14.6.6.3.3. Cancer therapy
14.6.6.3.4. Others
14.6.6.4. South Korea Microneedle Drug Delivery Systems Market Revenue
(US$ Mn) and Forecasts, By End Users
14.6.6.4.1. Hospitals
14.6.6.4.2. Surgical Centers
14.6.6.4.3. Diagnostic Laboratories
14.6.6.4.4. Research Laboratories
14.6.6.4.5. Others
14.6.7. Southeast
Asia
14.6.7.1. Southeast Asia Microneedle Drug Delivery Systems Market
Revenue (US$ Mn) and Forecasts, By Type
14.6.7.1.1. Solid
14.6.7.1.2. Hollow
14.6.7.1.3. Coated
14.6.7.1.4. Dissolving
14.6.7.1.5. Others
14.6.7.2. Southeast Asia Microneedle Drug Delivery Systems Market
Revenue (US$ Mn) and Forecasts, By Material
14.6.7.2.1. Silicon
14.6.7.2.2. Titanium
14.6.7.2.3. Stainless steel
14.6.7.2.4. Polymers
14.6.7.2.5. Others
14.6.7.3. Southeast Asia Microneedle Drug Delivery Systems Market
Revenue (US$ Mn) and Forecasts, By Application
14.6.7.3.1. Drug Delivery
14.6.7.3.1.1. Protein
14.6.7.3.1.2. Water-Soluble
Molecule
14.6.7.3.1.3. Others
14.6.7.3.2. Vaccine Delivery
14.6.7.3.3. Cancer therapy
14.6.7.3.4. Others
14.6.7.4. Southeast Asia Microneedle Drug Delivery Systems Market
Revenue (US$ Mn) and Forecasts, By End Users
14.6.7.4.1. Hospitals
14.6.7.4.2. Surgical Centers
14.6.7.4.3. Diagnostic Laboratories
14.6.7.4.4. Research Laboratories
14.6.7.4.5. Others
14.6.7.5. Southeast Asia Microneedle Drug Delivery Systems Market
Revenue (US$ Mn) and Forecasts, By Country
14.6.7.5.1. Indonesia
14.6.7.5.2. Thailand
14.6.7.5.3. Malaysia
14.6.7.5.4. Singapore
14.6.7.5.5. Rest of Southeast Asia
14.6.8. Rest of
Asia Pacific
14.6.8.1. Rest of Asia Pacific Microneedle Drug Delivery Systems Market
Revenue (US$ Mn) and Forecasts, By Type
14.6.8.1.1. Solid
14.6.8.1.2. Hollow
14.6.8.1.3. Coated
14.6.8.1.4. Dissolving
14.6.8.1.5. Others
14.6.8.2. Rest of Asia Pacific Microneedle Drug Delivery Systems Market
Revenue (US$ Mn) and Forecasts, By Material
14.6.8.2.1. Silicon
14.6.8.2.2. Titanium
14.6.8.2.3. Stainless steel
14.6.8.2.4. Polymers
14.6.8.2.5. Others
14.6.8.3. Rest of Asia Pacific Microneedle Drug Delivery Systems Market
Revenue (US$ Mn) and Forecasts, By Application
14.6.8.3.1. Drug Delivery
14.6.8.3.1.1. Protein
14.6.8.3.1.2. Water-Soluble
Molecule
14.6.8.3.1.3. Others
14.6.8.3.2. Vaccine Delivery
14.6.8.3.3. Cancer therapy
14.6.8.3.4. Others
14.6.8.4. Rest of Asia Pacific Microneedle Drug Delivery Systems Market
Revenue (US$ Mn) and Forecasts, By End Users
14.6.8.4.1. Hospitals
14.6.8.4.2. Surgical Centers
14.6.8.4.3. Diagnostic Laboratories
14.6.8.4.4. Research Laboratories
14.6.8.4.5. Others
14.7. Key
Segment for Channeling Investments
14.7.1. By
Country
14.7.2. By Type
14.7.3. By
Material
14.7.4. By
Application
14.7.5. By End
Users
15. Middle East and Africa Microneedle Drug Delivery Systems
Market Analysis and Forecasts, 2022 – 2030
15.1. Overview
15.1.1. Middle
East and Africa Microneedle Drug Delivery Systems Market Revenue (US$ Mn)
15.2. Middle
East and Africa Microneedle Drug Delivery Systems Market Revenue (US$ Mn) and
Forecasts, By Type
15.2.1. Solid
15.2.2. Hollow
15.2.3. Coated
15.2.4. Dissolving
15.2.5. Others
15.3. Middle
East and Africa Microneedle Drug Delivery Systems Market Revenue (US$ Mn) and
Forecasts, By Material
15.3.1. Silicon
15.3.2. Titanium
15.3.3. Stainless
steel
15.3.4. Polymers
15.3.5. Others
15.4. Middle
East and Africa Microneedle Drug Delivery Systems Market Revenue (US$ Mn) and
Forecasts, By Application
15.4.1. Drug
Delivery
15.4.1.1. Protein
15.4.1.2. Water-Soluble Molecule
15.4.1.3. Others
15.4.2. Vaccine
Delivery
15.4.3. Cancer
therapy
15.4.4. Others
15.5. Middle
East and Africa Microneedle Drug Delivery Systems Market Revenue (US$ Mn) and
Forecasts, By End Users
15.5.1. Hospitals
15.5.2. Surgical
Centers
15.5.3. Diagnostic
Laboratories
15.5.4. Research
Laboratories
15.5.5. Others
15.6. Middle
East and Africa Microneedle Drug Delivery Systems Market Revenue (US$ Mn) and
Forecasts, By Country
15.6.1. Saudi
Arabia
15.6.1.1. Saudi Arabia Microneedle Drug Delivery Systems Market Revenue
(US$ Mn) and Forecasts, By Type
15.6.1.1.1. Solid
15.6.1.1.2. Hollow
15.6.1.1.3. Coated
15.6.1.1.4. Dissolving
15.6.1.1.5. Others
15.6.1.2. Saudi Arabia Microneedle Drug Delivery Systems Market Revenue
(US$ Mn) and Forecasts, By Material
15.6.1.2.1. Silicon
15.6.1.2.2. Titanium
15.6.1.2.3. Stainless steel
15.6.1.2.4. Polymers
15.6.1.2.5. Others
15.6.1.3. Saudi Arabia Microneedle Drug Delivery Systems Market Revenue
(US$ Mn) and Forecasts, By Application
15.6.1.3.1. Drug Delivery
15.6.1.3.1.1. Protein
15.6.1.3.1.2. Water-Soluble
Molecule
15.6.1.3.1.3. Others
15.6.1.3.2. Vaccine Delivery
15.6.1.3.3. Cancer therapy
15.6.1.3.4. Others
15.6.1.4. Saudi Arabia Microneedle Drug Delivery Systems Market Revenue
(US$ Mn) and Forecasts, By End Users
15.6.1.4.1. Hospitals
15.6.1.4.2. Surgical Centers
15.6.1.4.3. Diagnostic Laboratories
15.6.1.4.4. Research Laboratories
15.6.1.4.5. Others
15.6.2. UAE
15.6.2.1. UAE Microneedle Drug Delivery Systems Market Revenue (US$ Mn)
and Forecasts, By Type
15.6.2.1.1. Solid
15.6.2.1.2. Hollow
15.6.2.1.3. Coated
15.6.2.1.4. Dissolving
15.6.2.1.5. Others
15.6.2.2. UAE Microneedle Drug Delivery Systems Market Revenue (US$ Mn)
and Forecasts, By Material
15.6.2.2.1. Silicon
15.6.2.2.2. Titanium
15.6.2.2.3. Stainless steel
15.6.2.2.4. Polymers
15.6.2.2.5. Others
15.6.2.3. UAE Microneedle Drug Delivery Systems Market Revenue (US$ Mn)
and Forecasts, By Application
15.6.2.3.1. Drug Delivery
15.6.2.3.1.1. Protein
15.6.2.3.1.2. Water-Soluble
Molecule
15.6.2.3.1.3. Others
15.6.2.3.2. Vaccine Delivery
15.6.2.3.3. Cancer therapy
15.6.2.3.4. Others
15.6.2.4. UAE Microneedle Drug Delivery Systems Market Revenue (US$ Mn)
and Forecasts, By End Users
15.6.2.4.1. Hospitals
15.6.2.4.2. Surgical Centers
15.6.2.4.3. Diagnostic Laboratories
15.6.2.4.4. Research Laboratories
15.6.2.4.5. Others
15.6.3. Egypt
15.6.3.1. Egypt Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Type
15.6.3.1.1. Solid
15.6.3.1.2. Hollow
15.6.3.1.3. Coated
15.6.3.1.4. Dissolving
15.6.3.1.5. Others
15.6.3.2. Egypt Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Material
15.6.3.2.1. Silicon
15.6.3.2.2. Titanium
15.6.3.2.3. Stainless steel
15.6.3.2.4. Polymers
15.6.3.2.5. Others
15.6.3.3. Egypt Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Application
15.6.3.3.1. Drug Delivery
15.6.3.3.1.1. Protein
15.6.3.3.1.2. Water-Soluble
Molecule
15.6.3.3.1.3. Others
15.6.3.3.2. Vaccine Delivery
15.6.3.3.3. Cancer therapy
15.6.3.3.4. Others
15.6.3.4. Egypt Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By End Users
15.6.3.4.1. Hospitals
15.6.3.4.2. Surgical Centers
15.6.3.4.3. Diagnostic Laboratories
15.6.3.4.4. Research Laboratories
15.6.3.4.5. Others
15.6.4. Kuwait
15.6.4.1. Kuwait Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Type
15.6.4.1.1. Solid
15.6.4.1.2. Hollow
15.6.4.1.3. Coated
15.6.4.1.4. Dissolving
15.6.4.1.5. Others
15.6.4.2. Kuwait Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Material
15.6.4.2.1. Silicon
15.6.4.2.2. Titanium
15.6.4.2.3. Stainless steel
15.6.4.2.4. Polymers
15.6.4.2.5. Others
15.6.4.3. Kuwait Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Application
15.6.4.3.1. Drug Delivery
15.6.4.3.1.1. Protein
15.6.4.3.1.2. Water-Soluble
Molecule
15.6.4.3.1.3. Others
15.6.4.3.2. Vaccine Delivery
15.6.4.3.3. Cancer therapy
15.6.4.3.4. Others
15.6.4.4. Kuwait Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By End Users
15.6.4.4.1. Hospitals
15.6.4.4.2. Surgical Centers
15.6.4.4.3. Diagnostic Laboratories
15.6.4.4.4. Research Laboratories
15.6.4.4.5. Others
15.6.5. South
Africa
15.6.5.1. South Africa Microneedle Drug Delivery Systems Market Revenue
(US$ Mn) and Forecasts, By Type
15.6.5.1.1. Solid
15.6.5.1.2. Hollow
15.6.5.1.3. Coated
15.6.5.1.4. Dissolving
15.6.5.1.5. Others
15.6.5.2. South Africa Microneedle Drug Delivery Systems Market Revenue
(US$ Mn) and Forecasts, By Material
15.6.5.2.1. Silicon
15.6.5.2.2. Titanium
15.6.5.2.3. Stainless steel
15.6.5.2.4. Polymers
15.6.5.2.5. Others
15.6.5.3. South Africa Microneedle Drug Delivery Systems Market Revenue
(US$ Mn) and Forecasts, By Application
15.6.5.3.1. Drug Delivery
15.6.5.3.1.1. Protein
15.6.5.3.1.2. Water-Soluble
Molecule
15.6.5.3.1.3. Others
15.6.5.3.2. Vaccine Delivery
15.6.5.3.3. Cancer therapy
15.6.5.3.4. Others
15.6.5.4. South Africa Microneedle Drug Delivery Systems Market Revenue
(US$ Mn) and Forecasts, By End Users
15.6.5.4.1. Hospitals
15.6.5.4.2. Surgical Centers
15.6.5.4.3. Diagnostic Laboratories
15.6.5.4.4. Research Laboratories
15.6.5.4.5. Others
15.6.6. Rest of
Middle East & Africa
15.6.6.1. Rest of Middle East & Africa Microneedle Drug Delivery
Systems Market Revenue (US$ Mn) and Forecasts, By Type
15.6.6.1.1. Solid
15.6.6.1.2. Hollow
15.6.6.1.3. Coated
15.6.6.1.4. Dissolving
15.6.6.1.5. Others
15.6.6.2. Rest of Middle East & Africa Microneedle Drug Delivery
Systems Market Revenue (US$ Mn) and Forecasts, By Material
15.6.6.2.1. Silicon
15.6.6.2.2. Titanium
15.6.6.2.3. Stainless steel
15.6.6.2.4. Polymers
15.6.6.2.5. Others
15.6.6.3. Rest of Middle East & Africa Microneedle Drug Delivery
Systems Market Revenue (US$ Mn) and Forecasts, By Application
15.6.6.3.1. Drug Delivery
15.6.6.3.1.1. Protein
15.6.6.3.1.2. Water-Soluble
Molecule
15.6.6.3.1.3. Others
15.6.6.3.2. Vaccine Delivery
15.6.6.3.3. Cancer therapy
15.6.6.3.4. Others
15.6.6.4. Rest of Middle East & Africa Microneedle Drug Delivery
Systems Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.6.4.1. Hospitals
15.6.6.4.2. Surgical Centers
15.6.6.4.3. Diagnostic Laboratories
15.6.6.4.4. Research Laboratories
15.6.6.4.5. Others
15.7. Key
Segment for Channeling Investments
15.7.1. By
Country
15.7.2. By Type
15.7.3. By
Material
15.7.4. By
Application
15.7.5. By End
Users
16. Latin America Microneedle Drug Delivery Systems Market
Analysis and Forecasts, 2022 – 2030
16.1. Overview
16.1.1. Latin
America Microneedle Drug Delivery Systems Market Revenue (US$ Mn)
16.2. Latin
America Microneedle Drug Delivery Systems Market Revenue (US$ Mn) and
Forecasts, By Type
16.2.1. Solid
16.2.2. Hollow
16.2.3. Coated
16.2.4. Dissolving
16.2.5. Others
16.3. Latin
America Microneedle Drug Delivery Systems Market Revenue (US$ Mn) and Forecasts,
By Material
16.3.1. Silicon
16.3.2. Titanium
16.3.3. Stainless
steel
16.3.4. Polymers
16.3.5. Others
16.4. Latin
America Microneedle Drug Delivery Systems Market Revenue (US$ Mn) and
Forecasts, By Application
16.4.1. Drug
Delivery
16.4.1.1. Protein
16.4.1.2. Water-Soluble Molecule
16.4.1.3. Others
16.4.2. Vaccine
Delivery
16.4.3. Cancer
therapy
16.4.4. Others
16.5. Latin
America Microneedle Drug Delivery Systems Market Revenue (US$ Mn) and
Forecasts, By End Users
16.5.1. Hospitals
16.5.2. Surgical
Centers
16.5.3. Diagnostic
Laboratories
16.5.4. Research
Laboratories
16.5.5. Others
16.6. Latin
America Microneedle Drug Delivery Systems Market Revenue (US$ Mn) and
Forecasts, By Country
16.6.1. Brazil
16.6.1.1. Brazil Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Type
16.6.1.1.1. Solid
16.6.1.1.2. Hollow
16.6.1.1.3. Coated
16.6.1.1.4. Dissolving
16.6.1.1.5. Others
16.6.1.2. Brazil Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Material
16.6.1.2.1. Silicon
16.6.1.2.2. Titanium
16.6.1.2.3. Stainless steel
16.6.1.2.4. Polymers
16.6.1.2.5. Others
16.6.1.3. Brazil Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By Application
16.6.1.3.1. Drug Delivery
16.6.1.3.1.1. Protein
16.6.1.3.1.2. Water-Soluble
Molecule
16.6.1.3.1.3. Others
16.6.1.3.2. Vaccine Delivery
16.6.1.3.3. Cancer therapy
16.6.1.3.4. Others
16.6.1.4. Brazil Microneedle Drug Delivery Systems Market Revenue (US$
Mn) and Forecasts, By End Users
16.6.1.4.1. Hospitals
16.6.1.4.2. Surgical Centers
16.6.1.4.3. Diagnostic Laboratories
16.6.1.4.4. Research Laboratories
16.6.1.4.5. Others
16.6.2. Argentina
16.6.2.1. Argentina Microneedle Drug Delivery Systems Market Revenue
(US$ Mn) and Forecasts, By Type
16.6.2.1.1. Solid
16.6.2.1.2. Hollow
16.6.2.1.3. Coated
16.6.2.1.4. Dissolving
16.6.2.1.5. Others
16.6.2.2. Argentina Microneedle Drug Delivery Systems Market Revenue
(US$ Mn) and Forecasts, By Material
16.6.2.2.1. Silicon
16.6.2.2.2. Titanium
16.6.2.2.3. Stainless steel
16.6.2.2.4. Polymers
16.6.2.2.5. Others
16.6.2.3. Argentina Microneedle Drug Delivery Systems Market Revenue
(US$ Mn) and Forecasts, By Application
16.6.2.3.1. Drug Delivery
16.6.2.3.1.1. Protein
16.6.2.3.1.2. Water-Soluble
Molecule
16.6.2.3.1.3. Others
16.6.2.3.2. Vaccine Delivery
16.6.2.3.3. Cancer therapy
16.6.2.3.4. Others
16.6.2.4. Argentina Microneedle Drug Delivery Systems Market Revenue
(US$ Mn) and Forecasts, By End Users
16.6.2.4.1. Hospitals
16.6.2.4.2. Surgical Centers
16.6.2.4.3. Diagnostic Laboratories
16.6.2.4.4. Research Laboratories
16.6.2.4.5. Others
16.6.3. Rest of
Latin America
16.6.3.1. Rest of Latin America Microneedle Drug Delivery Systems Market
Revenue (US$ Mn) and Forecasts, By Type
16.6.3.1.1. Solid
16.6.3.1.2. Hollow
16.6.3.1.3. Coated
16.6.3.1.4. Dissolving
16.6.3.1.5. Others
16.6.3.2. Rest of Latin America Microneedle Drug Delivery Systems Market
Revenue (US$ Mn) and Forecasts, By Material
16.6.3.2.1. Silicon
16.6.3.2.2. Titanium
16.6.3.2.3. Stainless steel
16.6.3.2.4. Polymers
16.6.3.2.5. Others
16.6.3.3. Rest of Latin America Microneedle Drug Delivery Systems Market
Revenue (US$ Mn) and Forecasts, By Application
16.6.3.3.1. Drug Delivery
16.6.3.3.1.1. Protein
16.6.3.3.1.2. Water-Soluble
Molecule
16.6.3.3.1.3. Others
16.6.3.3.2. Vaccine Delivery
16.6.3.3.3. Cancer therapy
16.6.3.3.4. Others
16.6.3.4. Rest of Latin America Microneedle Drug Delivery Systems Market
Revenue (US$ Mn) and Forecasts, By End Users
16.6.3.4.1. Hospitals
16.6.3.4.2. Surgical Centers
16.6.3.4.3. Diagnostic Laboratories
16.6.3.4.4. Research Laboratories
16.6.3.4.5. Others
16.7. Key
Segment for Channeling Investments
16.7.1. By
Country
16.7.2. By Type
16.7.3. By
Material
16.7.4. By
Application
16.7.5. By End
Users
17. Competitive Benchmarking
17.1. Brand
Benchmarking
17.2. Market
Share Analysis, 2021
17.3. Global
Presence and Growth Strategies
17.3.1. Mergers
and Acquisitions
17.3.2. Product
Launches
17.3.3. Investments
Trends
17.3.4. R&D
Initiatives
18. Player Profiles
18.1. 3M
Company
18.1.1. Company
Details
18.1.2. Company
Overview
18.1.3. Product
Offerings
18.1.4. Key
Developments
18.1.5. Financial
Analysis
18.1.6. SWOT
Analysis
18.1.7. Business
Strategies
18.2. AdminMed
/ nanoBioSciences LLC
18.2.1. Company
Details
18.2.2. Company
Overview
18.2.3. Product
Offerings
18.2.4. Key
Developments
18.2.5. Financial
Analysis
18.2.6. SWOT
Analysis
18.2.7. Business Strategies
18.3. CosMED Pharmaceutical Co. Ltd.
18.3.1. Company
Details
18.3.2. Company
Overview
18.3.3. Product
Offerings
18.3.4. Key
Developments
18.3.5. Financial
Analysis
18.3.6. SWOT
Analysis
18.3.7. Business Strategies
18.4. ENDODERMA CO., LTD.
18.4.1. Company
Details
18.4.2. Company
Overview
18.4.3. Product
Offerings
18.4.4. Key
Developments
18.4.5. Financial
Analysis
18.4.6. SWOT
Analysis
18.4.7. Business Strategies
18.5. Microdermics Inc.
18.5.1. Company
Details
18.5.2. Company
Overview
18.5.3. Product
Offerings
18.5.4. Key
Developments
18.5.5. Financial
Analysis
18.5.6. SWOT
Analysis
18.5.7. Business Strategies
18.6. Nanopass Tech
18.6.1. Company
Details
18.6.2. Company
Overview
18.6.3. Product
Offerings
18.6.4. Key
Developments
18.6.5. Financial
Analysis
18.6.6. SWOT
Analysis
18.6.7. Business Strategies
18.7. NITTO DENKO CORPORATION
18.7.1. Company
Details
18.7.2. Company
Overview
18.7.3. Product
Offerings
18.7.4. Key
Developments
18.7.5. Financial
Analysis
18.7.6. SWOT
Analysis
18.7.7. Business Strategies
18.8. QUADMEDICINE
18.8.1. Company
Details
18.8.2. Company
Overview
18.8.3. Product
Offerings
18.8.4. Key
Developments
18.8.5. Financial
Analysis
18.8.6. SWOT
Analysis
18.8.7. Business Strategies
18.9. Raphas Co., Ltd.
18.9.1. Company
Details
18.9.2. Company
Overview
18.9.3. Product
Offerings
18.9.4. Key
Developments
18.9.5. Financial
Analysis
18.9.6. SWOT
Analysis
18.9.7. Business Strategies
18.10. SNvia Co. Ltd.
18.10.1. Company
Details
18.10.2. Company
Overview
18.10.3. Product
Offerings
18.10.4. Key
Developments
18.10.5. Financial
Analysis
18.10.6. SWOT
Analysis
18.10.7. Business Strategies
18.11. TheraJect, Inc.
18.11.1. Company
Details
18.11.2. Company
Overview
18.11.3. Product
Offerings
18.11.4. Key
Developments
18.11.5. Financial
Analysis
18.11.6. SWOT
Analysis
18.11.7. Business Strategies
18.12. Trelleborg Group
18.12.1. Company
Details
18.12.2. Company
Overview
18.12.3. Product
Offerings
18.12.4. Key
Developments
18.12.5. Financial
Analysis
18.12.6. SWOT
Analysis
18.12.7. Business Strategies
18.13. VAXXAS
18.13.1. Company
Details
18.13.2. Company
Overview
18.13.3. Product
Offerings
18.13.4. Key
Developments
18.13.5. Financial
Analysis
18.13.6. SWOT
Analysis
18.13.7. Business Strategies
18.14. Zealand Pharma A/S
18.14.1. Company
Details
18.14.2. Company
Overview
18.14.3. Product
Offerings
18.14.4. Key
Developments
18.14.5. Financial
Analysis
18.14.6. SWOT
Analysis
18.14.7. Business Strategies
18.15. Zosano Pharma Corporation
18.15.1. Company
Details
18.15.2. Company
Overview
18.15.3. Product
Offerings
18.15.4. Key
Developments
18.15.5. Financial
Analysis
18.15.6. SWOT
Analysis
18.15.7. Business Strategies
18.16. Other Market Participants
19. Key Findings
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
